Everbright is China’s cross-border investment and asset management company.
Business Model:
Revenue: $0
Employees: 201-500
Address:
City: Wan Chai
State: Hong Kong Island
Zip:
Country: Hong Kong
China Everbright Limited (“Everbright”, stock code: 165.HK) was established at Hong Kong in 1997, Everbright persistently pursues its “Macro Asset Management” strategy, with specific focuses on cross-border asset management and investment business. Over the past years, Everbright manages series of private equity funds, venture capital funds, sector focus funds, mezzanine funds, hedge funds and principal investment as operated via an international management platform, and provides overseas investors with opportunities to explore and invest in companies with fast growing potential in Mainland China. On the other hand, Everbright also seeks investment opportunities from overseas and provides diversified financial services for its clients in Mainland China. China Everbright Limited, being a member of China Everbright Group, is the second largest shareholder of Everbright Securities (stock code: 601788.SH), a strategic shareholder of China Everbright Bank (stock code: 601818.SH, 6818.HK), the controlling shareholder of the Hong Kong-listed China Aircraft Leasing Group Holdings Limited (stock code: 1848.HK) and the second largest shareholder of the Singapore-listed Ying Li International Real Estate Limited(stock code:5DM. SGX). After the launch of "Shanghai-Hong Kong Stock Connect" on 10 April 2014, Everbright becomes one of the first batch of specific stocks listed on The Stock Exchange of Hong Kong which can be directly traded by Mainland investors. Through upholding the philosophy of “Making Wealth Simple”, Everbright leverages on its own substantial financial strength, as well as the position and influence of China Everbright Group and its affiliated companies in the financial industry in China, and has successfully built huge cross-border social and business networks in Hong Kong and the Mainland, and established a reputable image in the market.
Contact Phone:
Contact Email:
Listed Exchange:
SSE
IPO Date:
12/3/1992
Ticker Symbol:
600622
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2016 | Ambrx | Venture Round | 0 |
8/2019 | Gary &a; Bros | Series A | - |
10/2021 | Jiuduuoduo | Series A | 16M |
11/2020 | Hedonova | Series A | 0 |
4/2020 | T11 Food Market | Series A | 0 |
10/2018 | T11 Food Market | Angel Round | 0 |
7/2017 | Terminus Technologies | Series A | 73.5M |
5/2016 | Terminus Technologies | Series A | - |
6/2014 | ReSound | Series A | 6M |
4/2017 | Mylio | Venture Round | 25M |
7/2015 | SINOWEL | Series C | 4.8M |
11/2016 | Miaopai | Series E | 500M |
9/2016 | Shanghai Film Art Academy | Venture Round | - |
1/2017 | ESR | Private Equity Round | 0 |
4/2019 | InDeco China | Series B | - |
4/2019 | Tongdun Technology | Series D | 100M |
10/2018 | Terminus Technologies | Series B | 172.7M |
6/2018 | Mevion Medical Systems | Private Equity Round | 150M |
11/2007 | lijiababy | Angel Round | 404.7k |
4/2020 | Yeelight | Series C | 0 |
11/2019 | Juvenile Get | Series A | 0 |
3/2013 | Knowgene | Series A | 1.6M |
8/2011 | ReSound | Angel Round | 4.6M |
9/2021 | IASO Biotherapeutics | Series C | 0 |
9/2021 | Reforgene Medicine | Series A | - |
2/2018 | lijiababy | Series C | 4.7M |
4/2018 | Arctic Green Energy | Venture Round | 150M |
11/2013 | Amcare Women&s;s and Children&s;s Hospital | Private Equity Round | 100M |
12/2020 | WT Microtech Medical | Series D | 0 |
3/2022 | Grit Science | Series A | 0 |
6/2017 | Dt Dream | Series A | 110M |
2/2019 | Nreal | Series A | 16M |
8/2019 | Terminus Technologies | Series C | 0 |
11/2017 | SICHUAN TE QU EDUCATION MANAGEMENT Co., Ltd | Angel Round | 453.7k |
5/2018 | Lifetech Scientific Co, Ltd | Post-IPO Equity | - |
5/2018 | DiYiDan | Series C | 4.7M |
2/2011 | TaiRui | Series A | 1.5M |
1/2010 | iSoftStone | Series C | - |
11/2018 | NetEase Cloud Music | Series B | 600M |
3/2019 | Googut Wine &a; Spirits | Venture Round | 149M |
9/2018 | Yijiupi | Series D | 200M |
3/2022 | Grit Science | Series A | 0 |
10/2021 | Jiuduuoduo | Series A | 0 |
9/2021 | IASO Biotherapeutics | Series C | 0 |
9/2021 | Reforgene Medicine | Series A | - |
12/2020 | WT Microtech Medical | Series D | 0 |
11/2020 | Hedonova | Series A | 0 |
4/2020 | T11 Food Market | Series A | 0 |
4/2020 | Yeelight | Series C | 0 |
11/2019 | Juvenile Get | Series A | 0 |
8/2019 | Terminus Technologies | Series C | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
5/2016 | Beijing Huichen Nursing Home Management Co., Ltd. | |
10/2014 | Burke E. Porter Machinery |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|